相关实验视频
Updated: Jan 6, 2026
01:19
Mitral Valve Prolapse III: Nursing Management
Published on: June 19, 2025
252
酵母中间体在cis中起作用,抑制相邻序列的介质基因转换
1Department of Biology, Yale University, New Haven, Connecticut 06511.
Cell
|March 25, 1988
概括
酵母中间体 (CEN3) 抑制了介质重组. 它抑制交叉转换和基因转换时同卵性,并损害受体的能力时半卵性,表明受体分子启动重组.
科学领域:
- 遗传学 是一个遗传学.
- 分子生物学分子生物学
- 酵母生物学的酵母生物学
背景情况:
- 介质重组对于遗传多样性至关重要.
- 中介质在染色体分离中发挥作用.
- 中心分子对重组启动的影响尚未完全理解.
研究的目的:
- 调查酵母中位素 (CEN3) 在调节介质重组中的作用.
- 确定CEN3在同卵性或半卵性时如何影响交叉和基因转换.
主要方法:
- 分析不同CEN3配置 (同和半) 的酵母菌株中中介性重组频率.
- 在与CEN3.3相邻的序列中对交叉和基因转换事件的量化.
主要成果:
- 同卵性CEN3双向抑制交叉并强烈抑制基因转换.
- 在基因转换过程中,CEN3双胞胎损害了相邻DNA段的受体能力.
- 这些发现表明CEN3干扰着近端重组事件的启动.
结论:
- 酵母染色体III (CEN3) 的中间体活性抑制介质重组.
- CEN3的抑制作用根据其配置 (同卵性与半卵性) 不同.
- 结果支持一个受体分子对于启动酵母中介质重组的模型至关重要.
相关概念视频
Mitral Valve Prolapse III: Nursing Management
252
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
252
Cancer Vaccines
917
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
917
Development of Immunocompetence
759
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
759
Vaccinations
51.1K
Overview
51.1K
Healthcare Associated Infections II: Preventive Measures
3.5K
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
3.5K
Teratogenicity
3.9K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.9K